X
Xeris Biopharma Holdings, Inc. (XERS)
NMS – Real Time Price. Currency in USD
6.26
+0.12 (1.95%)
At close: May 12, 2026, 4:00 PM EDT
6.23
-0.03 (-0.48%)
After-hours: May 12, 2026, 7:25 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
6.26
+0.12 (1.95%)
At close: May 12, 2026, 4:00 PM EDT
6.23
-0.03 (-0.48%)
After-hours: May 12, 2026, 7:25 PM EDT
Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. It offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
| Name | Position |
|---|---|
| Dr. Anh T. Nguyen M.B.A., M.D. | Chief Medical Officer |
| Mr. Brian Conner | SVP of Quality and Chief Compliance & Risk Officer |
| Mr. John P. Shannon | CEO & Director |
| Mr. Kevin McCulloch | President & COO |
| Mr. Steven M. Pieper | Chief Financial Officer |
| Ms. Allison Wey | Senior Vice President of Investor Relations & Corporate Communications |
| Ms. Beth P. Hecht J.D. | Chief Legal Officer & Corporate Secretary |
| Ms. Kendal Korte | Senior Vice President of Human Resources |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | xers-20260507.htm |
| 2026-04-23 | DEF 14A | xers-20260423.htm |
| 2026-04-21 | 8-K | xers-20260420.htm |
| 2026-03-02 | S-8 | xeris-formsx82026.htm |
| 2026-03-02 | 10-K | xers-20251231.htm |
| 2026-02-27 | 8-K | xers-20260226.htm |
| 2026-01-08 | 8-K | xers-20260108.htm |
| 2025-12-01 | 8-K | xers-20251201.htm |
| 2025-11-06 | 8-K | xers-20251106.htm |
| 2025-08-07 | 8-K | xers-20250807.htm |